HRT Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.3M Buy
467,070
+397,985
+576% +$20.7M 0.11% 95
2025
Q1
$4.41M Buy
+69,085
New +$4.41M 0.03% 397
2024
Q3
Sell
-9,155
Closed -$479K 2522
2024
Q2
$479K Buy
+9,155
New +$479K ﹤0.01% 1209
2024
Q1
Sell
-78,318
Closed -$2.89M 2467
2023
Q4
$2.89M Sell
78,318
-3,616
-4% -$134K 0.02% 475
2023
Q3
$3.13M Buy
81,934
+50,127
+158% +$1.91M 0.03% 412
2023
Q2
$1.15M Sell
31,807
-41,822
-57% -$1.51M 0.01% 812
2023
Q1
$2.81M Buy
73,629
+11,067
+18% +$423K 0.03% 426
2022
Q4
$3.56M Buy
62,562
+44,817
+253% +$2.55M 0.05% 349
2022
Q3
$701K Sell
17,745
-60,629
-77% -$2.4M 0.01% 1176
2022
Q2
$3.45M Buy
+78,374
New +$3.45M 0.04% 358
2022
Q1
Sell
-35,547
Closed -$1.43M 3093
2021
Q4
$1.43M Buy
+35,547
New +$1.43M 0.01% 760
2021
Q2
Sell
-21,092
Closed -$879K 2982
2021
Q1
$879K Buy
+21,092
New +$879K 0.01% 1136
2020
Q1
Sell
-13,789
Closed -$244K 872
2019
Q4
$244K Sell
13,789
-6,817
-33% -$121K 0.01% 801
2019
Q3
$319K Buy
+20,606
New +$319K 0.02% 802